Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

NN Inc (NNBR)

NASDAQ
Currency in USD
Disclaimer
3.970
+0.150(+3.93%)
Closed
After Hours
4.080+0.110(+2.771%)

NNBR Comments

If elon and tesla mentions then better buy this stock.
Warren Veltmen navigated Autocam through the 2009 crisis just as rock Baty did with NNBR.. NN will exceed to leverage covenants in August for FCF will be positive for Q2 with, > $70 in liquidy... the business will survive and then assets need to be sold starting with mobile for $200m a loss to book but great for multiples. The paragon medical centric business with < 4x leverage is worth $18 share alone. I'll remain long but need to see announcements prior to Q2 results call. end of July announce is my pick for now
91% Must be hedge fund. Maybe legion partners added to position
better trend today up 70÷
why why.... going down everyday...
Expect an announcement by April. Split medical into a separate company could be best option. No time to sell mobile today
So here's the math NN sells Mobile for $200m, EBITDA multiple goes to 8X immediately and stock goes to $30 or NN is sold for debt plus a little and stock goes to $24 . Either option is 3X growth in 12 months
Hope Tom earns his ****salary and 90÷ bonus
Next CEO, Tom, made 1st step. Tom and Warren to swap roles by mid 2020?
down 5%
Warren spoke
maybe Warren should say a few words?
good job Bob...
Time for Bob Brunner to go. Chairman is accountable too!
Forward PE is now less than 5
new CFO announcement should be today after the bell
Q2 is pivotal
A good Q1 and Q2 forecast tonight ?
Mr Holder has lost the confidence of those who own the company Good strategy but too much BS. He could not even remember his own 3.5 debt to EBITDA goal from the last investor conference. Now saying 4.5 which is a huge miss Time for Rich to go. May board meeting decision? legion may drive this. Accountability!
February 14th or 15th seems to be best date for PGS announcement and 2019 guidance.
Good move on the fixed interest rate and 6 basis point benefit. That's worth $420k in annual earnings. Next step, S.W. needs to be replaced on the board
Here's another way to look at the math in a very non Buffet way. NN before Rich had a market cap of ~$200m. Autocam was bought for $330m, PEP for $615M, Paragon for $375M and Bridgemedica and a few other investments for ~$50m, minus the $375m PBC was sold for. So assuming any reasonable degree on competence in due diligence and assuming zero synergies, this says the stock should be $30 once the new run rate is demonstrated in 2019.
Rich and Paul should move forward on the PGS announcement and include 2019 guidance with a clear roadmap on the growth by product segment
2019 EBITDA will be > $174M with a Medical and Industrial centric end market focus. A 2X EBITDA multiple will not last long.....
Do the math on the strategic plan presented in September If NN hits 80÷ of there stated five year goals the stock will be well above $60 The strategy makes perfect sense They just need to execute
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.